Automated pharmacy databases and behavioral health care quality assurance

Evaluation Review

Volumn 21, Issue 3, 1997, Pages 371-378

  McFarland, Bentson H ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FACTUAL DATABASE; HEALTH CARE QUALITY; HUMAN; MEDICAL INFORMATION SYSTEM; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; REVIEW; STANDARD; UNITED STATES;

CLINICAL PHARMACY INFORMATION SYSTEMS; DATABASES, FACTUAL; HUMANS; MENTAL HEALTH SERVICES; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 0031172899     PISSN: 0193841X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0193841X9702100312     Document Type: Article

References (45)

1. Agency for Health Care Policy and Research Depression Guideline Panel. 1993. Clinical practice guideline: Depression in primary care 2. Treatment of major depression. Publication no. 93-0551. Rockville, MD: Agency for Health Care Policy and Research.
2. American Managed Behavioral Healthcare Association (AMBHA). 1995. Performance measures for managed behavioral healthcare programs. Washington, DC: AMBHA.
3. Andrade, S. E., A. M. Walker, L. K. Gottlieb, et al. 1995. Discontinuation of antihyperlipidemic drugs - Do rates reported in clinical trials reflect rates in primary care settings? New England Journal of Medicine 332:1125-31.
4. Characteristics of clinical indicators. 1989. Quality Review Bulletin 15:330-9.
5. Barker, S., N. Barron, B. H. McFarland, et al. 1994. A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Mental Health Journal 30:363-82.
6. _. 1994. A community ability scale for chronically mentally ill consumers: Part II. Applications. Community Mental Health Journal 30:459-72.
7. Basco, M. R., and A. J. Rush. 1995. Compliance with pharmacotherapy in mood disorders. Psychiatric Annals 25:269-79.
8. Broadhead, W. E. 1994. Misdiagnosis of depression: Physicians contribute to the stigmatization of mental illness. Archives of Family Medicine 3:319-20.
9. Calabrese, J. R., C. Bowden, and M. J. Woyshville. 1994. Lithium and the anticonvulsants in the treatment of bipolar disorder. In Psychopharmacology: The fourth generation of progress, edited by F. E. Bloom and D. J. Kupfer. New York: Raven.
10. Csernansky, J. B., and J. G. Newcomer. 1994. Maintenance drug treatment for schizophrenia. In Psychopharmacology: The fourth generation of progress, edited by F. E. Bloom and D. J. Kupfer. New York: Raven.
11. Dickey, B. 1995. The development of report cards for mental health care. In Outcomes assessment in clinical practice, edited by L. I. Sedere and B. Dickey. Baltimore, MD: Williams and Wilkins.
12. Ford, D. E. 1994. Recognition and underrecognition of mental disorders in adult primary care. In Mental disorders in primary care, edited by J. Miranda, A. A. Hohmann, C. C. Attkisson, and D. B. Larson. San Francisco: Jossey-Bass.
13. Frank, E., J. F. Karp, and A. J. Rush. 1993. Efficacy of treatments for major depression. Psychopharmacology Bulletin 29:457-76.
14. Gelenberg, A. J., and H. S. Hopkins. 1993. Report on efficacy of treatment for bipolar disorder. Psychopharmacology Bulletin 29:447-56.
15. Gelenberg, A. J., J. M. Kane, M. B. Keller, et al. 1989. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine 321:1489-93.
16. Hartzema, A. G., and E. M. Perfetto. 1991. Sources and effects of drug exposure and unintended effect misclassification in pharmacoepidemiologic studies. In Pharmacoepidemiology: An introduction, 2nd ed., edited by A. G. Hartzema, M. S. Porta, and H. H. Tilson. Cincinnati, OH: Harvey Whitney Books.
17. Johnson, R. E., and B. H. McFarland. 1996. Lithium use and discontinuation in a health maintenance organization. American Journal of Psychiatry 153:993-1000.
18. Johnson, R. E., and W. M. Vollmer. 1991. Comparing sources of drug data about the elderly. Journal of the American Geriatrics Society 39:1079-84.
19. Jones, J. K., L. Gorkin, J. F. Lian, et al. 1995. Discontinuation of and changes in treatment after start of new course of antihypertensive drugs: A study of a United Kingdom population. British Medical Journal 311:293-5.
20. Kane, J. M., D. L. Evans, S. J. Fiester, et al. 1992. Psychopharmacological screening criteria. In Manual of psychiatric quality assurance, edited by M. R. Mattson and G. F. Wilson. Washington, DC: American Psychiatric Association.
21. Keith, S. J., and S. M. Mathews. 1993. Introduction. Psychopharmacology Bulletin 29:427-30.
22. Laffel, G., and D. Blumenthal. 1989. The case for using industrial quality management sciences in health care organizations. Journal of the American Medical Association 262:2869-73.
23. Leape, L. I. 1990. Practice guidelines and standards: An overview. Quality Review Bulletin 16:42-9.
24. _. 1995. Translating medical science into medical practice: Do we need a national medical standards board? Journal of the American Medical Association 273:1534-7.
25. Lurie, N., M. Popkin, M. Dysken, et al. 1992. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71.
26. McKenzie, D. A., J. Semradek, B. McFarland, et al. 1995. The use of computerized claims data for estimating drug use among elderly nursing home residents: Reliability issues. Poster presented at the Annual Gerontological Society of America Conference, November, Los Angeles.
27. Montgomery, S. A. 1995. Selective serotonin reuptake inhibitors in the acute treatment of depression. In Psychopharmacology: The fourth generation of progress, edited by F. E. Bloom and D. J. Kupfer. New York: Raven.
28. National Committee for Quality Assurance (NCQA). 1995. HEDIS 2.5 data submission forms. Washington, DC: NCQA.
29. Rogers, W. H., K. B. Wells, L. S. Meredith, et al. 1993. Outcomes for adult outpatients with depression under prepaid or fee-for-service financing. Archives of General Psychiatry 50:517-25.
30. Rokstad, K., J. Straand, and P. Fugelli. 1995. Can drug treatment be improved by feedback on prescribing profiles combined with therapeutic recommendations? A prospective, controlled trial in general practice. Journal of Clinical Epidemiology 48:1061-8.
31. Rost, K., G. R. Smith, D. B. Mathews, and B. Guise. 1994. The deliberate misdiagnosis of major depression in primary care. Archives of Family Medicine 3:333-7.
32. Schooler, N. R., and S. J. Keith. 1993. The clinical research base for the treatment of schizophrenia. Psychopharmacology Bulletin 29:431-46.
33. Serradell, J., D. C. Bjornson, and A. G. Hartzema. 1991. Drug utilization studies: Sources and methods. In Pharmacoepidemiology: An introduction, 2nd ed., edited by A. G. Hartzema, M. S. Porta, and H. H. Tilson. Cincinnati, OH: Harvey Whitney Books.
34. Shorr, R. I., R. L. Fought, and W. A. Ray. 1994. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. Journal of the American Medical Association 271:358-62.
35. Simon, G. E., E.H.B. Lin, W. Katon, et al. 1995. Outcomes of "inadequate" antidepressant treatment. Journal of General Internal Medicine 10:663-70.
36. Simon, G. E., M. VonKorff, E. H. Wagner, and W. Barlow. 1993. Patterns of antidepressant use in community practice. General Hospital Psychiatry 15:399-408.
37. Song, F., N. Freemantle, T. A. Sheldon, et al. 1993. Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability. British Medical Journal 306:683-7.
38. Steiner, J. F., T. D. Koepsell, S. D. Fihn, and T. S. Inui. 1988. A general method of compliance assessment using centralized pharmacy records: Description and validation. Medical Care 26:814-23.
39. Stephenson, B. J., B. H. Rowe, R. B. Haynes, et al. 1993. Is this patient taking the treatment as prescribed? Journal of the American Medical Association 269:2779-81.
40. Sturm, R., and K. B. Wells. 1995. How can care for depression become more cost-effective? Journal of the American Medical Association 273:51-8.
41. Tamblyn, R., G. Lavoie, L. Petrella, and J. Monette. 1995. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. Journal of Clinical Epidemiology 48:999-1009.
42. Taylor, D. 1992. The Joint Commission quality assessment and improvement model. In Manual of psychiatric quality assurance, edited by M. R. Mattson and G. F. Wilson. Washington, DC: American Psychiatric Association.
43. Weiner, J. P., S. T. Parente, D. W. Garnick, et al. 1995. Variation in office-based quality: A claims based profile of care provided to Medicare patients with diabetes. Journal of the American Medical Association 273:1503-8.
44. Wells, K. B., R. D. Hays, A. Burnam, et al. 1989. Detection of depressive disorder for patients receiving prepaid or fee-for-service care: Results from the Medical Outcomes Study. Journal of the American Medical Association 262:3298-302.
45. Wells, K. B., W. Katon, B. Rogers, and P. Camp. 1994. Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study. American Journal of Psychiatry 151:694-700.